[
    [
        {
            "time": "2019-10-14",
            "original_text": "机构、高管争相买入的业绩暴增股 3股机构已抢筹上亿！多股已被大股东偷偷增持",
            "features": {
                "keywords": [
                    "机构买入",
                    "高管增持",
                    "业绩暴增",
                    "抢筹上亿",
                    "大股东增持"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "机构、高管争相买入的业绩暴增股 3股机构已抢筹上亿！多股已被大股东偷偷增持",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-10-14",
            "original_text": "前三季净利预增30.45%-41.42% 贝达药业涨停",
            "features": {
                "keywords": [
                    "净利预增",
                    "贝达药业",
                    "涨停"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "前三季净利预增30.45%-41.42% 贝达药业涨停",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-10-14",
            "original_text": "贝达药业早盘最高涨幅超8% 前三季盈利超1.9亿",
            "features": {
                "keywords": [
                    "贝达药业",
                    "早盘涨幅",
                    "盈利超1.9亿"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业早盘最高涨幅超8% 前三季盈利超1.9亿",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-10-14",
            "original_text": "A股异动 | 贝达药业续涨逾9% 料前三季度净利增30.45%至41.42%",
            "features": {
                "keywords": [
                    "A股异动",
                    "贝达药业",
                    "续涨逾9%",
                    "净利增"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股异动 | 贝达药业续涨逾9% 料前三季度净利增30.45%至41.42%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-10-14",
            "original_text": "主力产品销售放量 贝达药业前三季度净利预增三成多",
            "features": {
                "keywords": [
                    "主力产品",
                    "销售放量",
                    "贝达药业",
                    "净利预增"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "主力产品销售放量 贝达药业前三季度净利预增三成多",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-10-14",
            "original_text": "贝达药业：预计前三季净利增长30.45%-41.42%",
            "features": {
                "keywords": [
                    "贝达药业",
                    "净利增长",
                    "前三季"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：预计前三季净利增长30.45%-41.42%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]